Prolyl isomerase PIN1 regulates the stability, transcriptional activity and oncogenic potential of BRD4
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prolyl isomerase PIN1 regulates the stability, transcriptional activity and oncogenic potential of BRD4
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 36, Pages 5177-5188
Publisher
Springer Nature
Online
2017-05-09
DOI
10.1038/onc.2017.137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BRD4 Phosphorylation Regulates HPV E2-Mediated Viral Transcription, Origin Replication, and Cellular MMP-9 Expression
- (2016) Shwu-Yuan Wu et al. Cell Reports
- BET bromodomain inhibitors in leukemia
- (2015) Faisal Basheer et al. EXPERIMENTAL HEMATOLOGY
- BRD4 Inhibitor Inhibits Colorectal Cancer Growth and Metastasis
- (2015) Yuan Hu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting BET bromodomains for cancer treatment
- (2015) Marie Jung et al. Epigenomics
- Pin1 is Overexpressed and Correlates with Poor Prognosis in Gastric Cancer
- (2014) Min Shi et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- An epigenomic approach to therapy for tamoxifen-resistant breast cancer
- (2014) Qin Feng et al. CELL RESEARCH
- Prolyl isomerase Pin1 in cancer
- (2014) Zhimin Lu et al. CELL RESEARCH
- BET bromodomain proteins are required for glioblastoma cell proliferation
- (2014) Chiara Pastori et al. Epigenetics
- Cross-Talk of Phosphorylation and Prolyl Isomerization of the C-terminal Domain of RNA Polymerase II
- (2014) S. Yogesha et al. MOLECULES
- Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
- (2014) Irfan A. Asangani et al. NATURE
- An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
- (2014) Birgit Knoechel et al. NATURE GENETICS
- MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy
- (2014) T-I Hsu et al. ONCOGENE
- Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151
- (2014) Stuart J. Gallagher et al. Pigment Cell & Melanoma Research
- Targeting receptor tyrosine kinases in gastric cancer
- (2014) Asahiro Morishita WORLD JOURNAL OF GASTROENTEROLOGY
- BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy
- (2013) M. F. Segura et al. CANCER RESEARCH
- The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy
- (2013) V. Proserpio et al. GENES & DEVELOPMENT
- Bromodomain and Extraterminal (BET) Protein Inhibition Suppresses Human T Cell Leukemia Virus 1 (HTLV-1) Tax Protein-mediated Tumorigenesis by Inhibiting Nuclear Factor κB (NF-κB) Signaling
- (2013) Xuewei Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression and Biological Relationship of Vascular Endothelial Growth Factor-A and Matrix Metalloproteinase-9 in Gastric Carcinoma
- (2013) S Yang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Phospho Switch Triggers Brd4 Chromatin Binding and Activator Recruitment for Gene-Specific Targeting
- (2013) Shwu-Yuan Wu et al. MOLECULAR CELL
- Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA
- (2013) Z Zou et al. ONCOGENE
- BRD4 Short Isoform Interacts with RRP1B, SIPA1 and Components of the LINC Complex at the Inner Face of the Nuclear Membrane
- (2013) Jude Alsarraj et al. PLoS One
- Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer
- (2012) Y-H Nicole Tsang et al. ONCOGENE
- Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins
- (2012) W. W. Lockwood et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathogenesis of NUT Midline Carcinoma
- (2011) Christopher A. French Annual Review of Pathology-Mechanisms of Disease
- Deletion of the Proline-Rich Region of the Murine Metastasis Susceptibility Gene Brd4 Promotes Epithelial-to-Mesenchymal Transition- and Stem Cell-Like Conversion
- (2011) J. Alsarraj et al. CANCER RESEARCH
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Bromodomains as therapeutic targets
- (2011) Susanne Muller et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation
- (2011) Nanping Ai et al. NUCLEIC ACIDS RESEARCH
- Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins
- (2011) Yih-Cherng Liou et al. TRENDS IN BIOCHEMICAL SCIENCES
- Suppression of inflammation by a synthetic histone mimic
- (2010) Edwige Nicodeme et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- The prolyl isomerase Pin1 regulates the NF-κB signaling pathway and interleukin-8 expression in glioblastoma
- (2009) G P Atkinson et al. ONCOGENE
- Brd4 Coactivates Transcriptional Activation of NF- B via Specific Binding to Acetylated RelA
- (2008) B. Huang et al. MOLECULAR AND CELLULAR BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started